Our leading experts continuously support physicians in their clinical decision-making with updated Clinical Practice Guidelines and Consensus Statements from European Society of Medical Oncology (ESMO).
GBG will present several posters at the San Antonio Breast Cancer Symposium 2023
The prognostic and predictive potential of CAV1/2 expression was analysed in the GeparSepto trial (GBG 069).
Das 21. Annual Scientific Meeting 2024 wird am 29.2. bis 1.3.2024 in Frankfurt stattfinden.
